Josep M. Llovet, MD, PhD

Institut d´Investigacions Biomediques August Pi i Sunyer (IDIBAPS) / ICAHN School of Medicine at Mount Sinai
Barcelona, Spain

Brief summary CV

Josep M. Llovet, MD, PhD is Professor of Medicine – Hepatic Oncology at University of Barcelona, Professor of Research-ICREA in the Liver Unit, IDIBAPS-Hospital Clínic of Barcelona and Director of the Liver Cancer Program and Full Professor of Medicine at the Icahn School of Medicine at Mount Sinai, New York and Director. Professor Llovet obtained his degree in Medicine and Surgery from the University of Barcelona in 1986 and his PhD from the Autonomous University of Barcelona in 1995.

Professor Llovet has been President, Secretary and Founder of the International Liver Cancer Association (ILCA) Chairman of the European Clinical Practice Guidelines of management of liver cancer (EASL-EORTC), President of the AASLD-SIG of Hepatobiliary neoplasia and member of the Educational Committee of EASL. He has published more than 335 articles in peer-reviewed journals (total citations 115,623, total impact factor 6077; h index 133-Google Scholar), > 55 chapters of books, and has delivered more than 610 lectures. He is Senior Editor of Clinical Cancer Research and has been recognized as Top-1% cited researcher in Clarivate Analytics (2014 to 2021).

He has devoted his career studying the pathogenesis and treatment of liver cancer and has received the AACR-Landon International Award (2009), the International Hans Popper award (2012), and was recognized as Fellow of the American Association for the Study of Liver Diseases (FAASLD-2015). He has received competitive funding for 95 projects including the European Commission and the US National Institute of Health

Presentation(s):

• Case Study Discussion of Early-stage HCC

  Thursday, June 30, 2022
  13:20 – 13:30

• Case Study Discussion of Intermediate-stage HCC

  Thursday, June 30, 2022
  13:45 – 14:00

• The Evolving Therapeutic Landscape of Unresectable / Advanced HCC

  Thursday, June 30, 2022
  14:00 – 14:10

• Case Study Discussion of Unresectable / Advanced HCC

  Thursday, June 30, 2022
  14:10 – 14:20

• Audience Discussion and Q&A

  Thursday, June 30, 2022
  14:20 – 14:35

• Pathogenesis and Subtypes of HCC

  Thursday, June 30, 2022
  14:50 – 15:10

• Cases With Panel Discussion: Management Strategy in HCC

  Thursday, June 30, 2022
  16:30 – 17:15